Biotechnology company
Appears in 1 story · Last updated Sep 29, 2026
As of September 2026: Developer of NouvSight001; advancing it into clinical trials in the US and China
About 1.5 million people worldwide have retinitis pigmentosa, an inherited disease that destroys the retina's light-sensing cells and can end in blindness. The only approved treatment covers patients with a specific RPE65 gene mutation — a small fraction of the affected population.
Updated Sep 29
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
